Study to Evaluate the Efficacy and Safety of Danirixin Co-administered With Oseltamivir in the Treatment of Adults Hospitalized With Influenza
Clinical trial NCT02927431 · TERMINATED
Trial details
- NCT number
- NCT02927431
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-19
- Primary completion
- 2017-05-24
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.